Business Description
Middle East Pharmaceutical Industries Co
ISIN : SA160G51UO10
Description
Middle East Pharmaceutical Industries Co is a holding company is engaged in manufacturing medicines, medicated and non-medicated creams and gels.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 3.41 | |||||
| Equity-to-Asset | 0.72 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | 0.17 | |||||
| Interest Coverage | 15.16 | |||||
| Piotroski F-Score | N/A/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 37.18 | |||||
| 9-Day RSI | 32.27 | |||||
| 14-Day RSI | 33.61 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.74 | |||||
| Quick Ratio | 2.74 | |||||
| Cash Ratio | 0.2 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.62 | |||||
| Forward Dividend Yield % | 0.62 | |||||
| 5-Year Yield-on-Cost % | 0.62 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 62.62 | |||||
| Operating Margin % | 20.83 | |||||
| Net Margin % | 17.62 | |||||
| FCF Margin % | 23.74 | |||||
| ROE % | 9.25 | |||||
| ROA % | 6.69 | |||||
| ROIC % | 7.51 | |||||
| ROC (Joel Greenblatt) % | 12.55 | |||||
| ROCE % | 10.29 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 76.29 | |||||
| PE Ratio without NRI | 76.29 | |||||
| PS Ratio | 13.45 | |||||
| PB Ratio | 7.05 | |||||
| Price-to-Tangible-Book | 7.06 | |||||
| Price-to-Free-Cash-Flow | 56.67 | |||||
| Price-to-Operating-Cash-Flow | 56.67 | |||||
| EV-to-EBIT | 66.2 | |||||
| EV-to-EBITDA | 66.2 | |||||
| EV-to-Revenue | 13.79 | |||||
| EV-to-FCF | 59.89 | |||||
| Price-to-Graham-Number | 4.89 | |||||
| Price-to-Net-Current-Asset-Value | 14.32 | |||||
| Earnings Yield (Greenblatt) % | 1.5 | |||||
| FCF Yield % | 1.77 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Middle East Pharmaceutical Industries Co Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ï·¼) | 176.952 | ||
| EPS (TTM) (ï·¼) | 1.56 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 33.61 | ||
| 14-Day ATR (ï·¼) | 2.590397 | ||
| 20-Day SMA (ï·¼) | 124.9 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (ï·¼) | 107 - 144.6 | ||
| Shares Outstanding (Mil) | 20 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Middle East Pharmaceutical Industries Co Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Middle East Pharmaceutical Industries Co Stock Events
| Event | Date | Price(ï·¼) | ||
|---|---|---|---|---|
| No Event Data | ||||
Middle East Pharmaceutical Industries Co Frequently Asked Questions
What is Middle East Pharmaceutical Industries Co(SAU:4016)'s stock price today?
The current price of SAU:4016 is ï·¼119.00. The 52 week high of SAU:4016 is ï·¼144.60 and 52 week low is ï·¼107.00.
When is next earnings date of Middle East Pharmaceutical Industries Co(SAU:4016)?
The next earnings date of Middle East Pharmaceutical Industries Co(SAU:4016) is .
Does Middle East Pharmaceutical Industries Co(SAU:4016) pay dividends? If so, how much?
The Dividend Yield %  of Middle East Pharmaceutical Industries Co(SAU:4016) is 0.62% (As of Today), Highest Dividend Payout Ratio of Middle East Pharmaceutical Industries Co(SAU:4016) was 0. The lowest was 0. And the median was 0. The  Forward Dividend Yield % of Middle East Pharmaceutical Industries Co(SAU:4016) is 0.62%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers